Trials / Sponsors / CENTOGENE GmbH Rostock
CENTOGENE GmbH Rostock
Industry · 57 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Investigating the Impact of Environmental Factors on the Transcriptomics Profile in Healthy Individuals Healthy Volunteers | — | 2023-05-09 |
| Active Not Recruiting | Omics Gaucher Study: Multiomic Approach Gaucher Disease | — | 2022-10-06 |
| Completed | Epidemiological Study in FRONtoTemporal Dementia Frontotemporal Dementia | — | 2021-09-01 |
| Completed | Unraveling Genetics of HypoPhosPhatasia (HPP Genetics) Hypophosphatasia | — | 2021-06-02 |
| Withdrawn | COVID-19 Epidemic Response Study Fever, Pneumonia, Cough | — | 2021-05-01 |
| Unknown | Biomarker for Friedreich's Ataxia (BioFridA) FXN Gene, FRDA, Hereditary Diseases | — | 2020-07-01 |
| Completed | Pyruvate Kinase Deficiency Epidemiological Study (PIECE) Pyruvate Kinase Deficiency | — | 2020-01-13 |
| Terminated | Hereditary Angioedema Kininogen Assay Hereditary Angioedema | — | 2019-09-01 |
| Unknown | Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Inborn Errors of Metabolism (iP Inborn Errors of Metabolism | — | 2019-08-01 |
| Completed | Biomarkers for Inborn Errors of Metabolism Inborn Errors of Metabolism, Biomarker | — | 2019-08-01 |
| Completed | Rostock International Parkinson's Disease Study (ROPAD) Parkinson´s Disease | — | 2019-05-30 |
| Completed | Peptide-based Immunization for Colon- and and Pancreas-carcinoma Colon Neoplasm, Colon Adenocarcinoma, Colon Cancer | — | 2019-04-01 |
| Completed | Establishment of Human Cellular Disease Models for Morquio Disease Morquio Disease | — | 2018-10-26 |
| Completed | Epidemiological Analysis for Hereditary Angioedema Disease Abdominal Pain, Functional Abdominal Pain | — | 2018-09-01 |
| Completed | Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease Lysosomal Storage Diseases, Gaucher Disease, Sphingolipidoses | — | 2018-08-27 |
| Withdrawn | Biomarker for Patients With Fabry Disease (BioFabry) Angiokeratomas, Chronic Kidney Disease, Ocular Abnormalities | — | 2018-08-20 |
| Withdrawn | Biomarker for Hypophosphatasia Disease (BioHypophos) Defective Mineralization | — | 2018-08-20 |
| Withdrawn | Biomarker for Cystinosis Disease: BioCystinosis (BioCystinosis) Renal Fanconi Syndrome, Photophobia, Hypophosphatemia | — | 2018-08-20 |
| Withdrawn | Biomarker for Sanfilippo Type A-B-C-D Disease (BioSanfilippo) Mental Retardation, Developmental Delay | — | 2018-08-20 |
| Withdrawn | Biomarker for Gaucher Disease: BioGaucher (BioGaucher) Splenomegaly, Hepatomegaly | — | 2018-08-20 |
| Withdrawn | Biomarker for Morquio Disease (BioMorquio) Morquio Syndrome, Accumulation of Mucopolysaccharides, Morquio Syndrome A | — | 2018-08-20 |
| Completed | Biomarker for Duchenne Muscular Dystrophy Increased Lordosis/Scoliosis, Hyporeflexia, Duchenne Muscular Dystrophy | — | 2018-08-20 |
| Withdrawn | Biomarker for Niemann Pick Type C Disease (BioNPC) Niemann-Pick Disease, Niemann-Pick Disease, Type C | — | 2018-08-20 |
| Withdrawn | Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH) Lipoprotein Lipase Deficiency, Inborn Error of Lipid Metabolism, Corneal Arcus | — | 2018-08-20 |
| Withdrawn | Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease Peripheral Neuropathy, Muscle Weakness | — | 2018-08-20 |
| Withdrawn | Biomarker for Krabbe Disease (BioKrabbe) Krabbe Disease | — | 2018-08-20 |
| Withdrawn | Biomarker for Maroteaux-Lamy Disease (BioMaroteaux) Lysosomal Storage Disease, Lung Diseases, Obstructive Sleep Apnoea | — | 2018-08-20 |
| Withdrawn | Biomarker for Gangliosidosis: BioGM1/BioGM2 (BioGM1/GM2) Hepato-splenomegaly, Dysostosis Multiplex, Seizures | — | 2018-08-20 |
| Withdrawn | Biomarker for Pompe Disease (BioPompe) Cardiac Diseases, Muscular Weakness, Hepato-splenomegaly | — | 2018-08-20 |
| Terminated | European Alpha-Mannosidosis Participant Immunodeficiency, Skeletal Abnormalities, Deafness | — | 2018-08-20 |
| Withdrawn | Biomarker for the Early Diagnosis and Monitoring in Tyrosinemia Type 1 (BioTyrosin) Tyrosinosis, Hepatorenal Tyrosinemia, Fumarylacetoacetase Deficiency | — | 2018-08-20 |
| Withdrawn | Biomarker for Wolman Disease (BioWolman) Acid Lipase Deficiency, Acid Cholesteryl Ester Hydrolase Deficiency, Wolman Type, Cholesterol Ester Storage Disease | — | 2018-08-20 |
| Withdrawn | Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy (BioTRAP) Transthyretin Amyloidosis, Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin Amyloid Cardiopathy | — | 2018-08-20 |
| Withdrawn | Biomarker for Glycogen Storage Diseases (BioGlycogen) Fructose Metabolism, Inborn Errors, Glycogen Storage Disease, Glycogen Storage Disease Type I | — | 2018-08-20 |
| Withdrawn | Biomarker for Farber Disease (BioFarber) Farber's Lipogranulomatosis, Ceramidase Deficiency, Hepatomegaly | — | 2018-08-20 |
| Terminated | Biomarker for Alport Syndrome (BioAlport) Nephritis, Hereditary, Hematuria-Nephropathy-Deafness Syndrome | — | 2018-08-20 |
| Withdrawn | Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML) Skeletal Abnormalities, Psychomotor Retardation | — | 2018-08-20 |
| Withdrawn | Biomarker for Gilbert Disease (BioGilbert) Meulengracht Syndrome, Hyperbilirubinemia, Unconjugated Benign Bilirubinemia | — | 2018-08-20 |
| Terminated | Biomarker for Cystic Fibrosis Chronic Nasal Congestion, Lung Infection, Breathlessness | — | 2018-08-20 |
| Withdrawn | Biomarker for Mannosidosis Disease (BioMannosidosis) Alpha-Mannosidase B Deficiency, Lysosomal Alpha B Mannosidosis, Alpha-Mannosidase Deficiency | — | 2018-08-20 |
| Withdrawn | Biomarker for Hurler Disease (BioHurler) Mucopolysaccharidosis Type I, Gargoylism, Metabolism, Inborn Errors | — | 2018-08-20 |
| Completed | Biomarker for Hereditary AngioEdema Disease C1 Esterase Inhibitor Deficiency, Angio Edema, C4 Deficiency | — | 2018-08-20 |
| Withdrawn | Biomarker for Sly Disease (MPS VII) (BioSly) Developmental Delay, Skeletal Abnormalities, Hepatomegaly | — | 2018-08-20 |
| Withdrawn | Biomarker for Creatine Deficiency Syndromes (BioCDS) Intellectual Disability, Developmental Delay, Movement Disorder | — | 2018-08-20 |
| Terminated | Biomarkers for Hunter Syndrome Hunter Syndrome, Mucopolysaccharidosis II, Hunter's Syndrome, Mild Form | — | 2018-08-20 |
| Withdrawn | Biomarker for Hyaline Fibromatosis Syndrome (BioHFS) Hyalinosis, Hyaline Membrane Disease, Juvenile Hyaline Fibromatosis | — | 2018-08-20 |
| Terminated | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom) Hypomelanotic Macules, Facial Angiofibroma, Shagreen Patches | — | 2018-08-01 |
| Completed | Induced Pluripotent Stem Cells for Niemann Pick Disease Niemann-Pick Diseases | — | 2018-06-19 |
| Completed | Establishment of Human Cellular Disease Models for Wilson Disease Wilson Disease | — | 2018-06-19 |
| Completed | TRAMmoniTTR Study Genetic Screening of an At-risk Population for hATTR and Monitoring of TTR Positive Subjects Transthyretin Amyloidosis, Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy | — | 2017-07-20 |
| Completed | Screening for the Transthyretin-Related Familial Amyloidotic Polyneuropathy (TTR FAP) Polyneuropathy, Amyloid, Neuropathic Pain, Cardiac Failure | — | 2016-12-01 |
| Withdrawn | Fabry and Cardiomyopathy (FaCard) Cerebrovascular Accident, Stroke, Acute, Cerebral Stroke | — | 2011-07-01 |
| Completed | Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype Parkinson Disease, Idiopathic Parkinson Disease | — | 2011-01-01 |
| Completed | Prevalence of Fabry Disease in a Defined Population at Risk - Patients Formerly Diagnosed With Multiple Sclero Multiple Sclerosis | — | 2011-01-01 |
| Completed | The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patient Fabry Disease, Fabry´s Disease, Anderson-Fabry Disease | — | 2010-12-01 |
| Completed | Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients Cerebrovascular Accident | — | 2008-01-01 |
| Completed | Stroke in Young Fabry Patients (sifap2): Characterization of the Stroke Rehabilitation Fabry Disease, Cerebrovascular Accident | — | 2007-07-01 |